MFS
PCRX icon

MSI Financial Services’s Pacira BioSciences PCRX Stock Holding History

MSI Financial Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
116
– – ﹤0.01% 3248
2016
Q3 		$4K Hold
116
– – ﹤0.01% 3245
2016
Q2 		$4K Hold
116
– – ﹤0.01% 3252
2016
Q1 		$6K Hold
116
– – ﹤0.01% 3075
2015
Q4 		$9K Buy
+116
New +$6.57K ﹤0.01% 2773

Other funds holding PCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

MSI Financial Services's PCRX Position: Q4 2016 in Review

MSI Financial Services held its Pacira BioSciences (PCRX) position steady in Q4 2016 at 116 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3248.

MSI Financial Services first reported a position in PCRX in Q4 2015 and has held it in 5 quarters since. The position peaked at $9K in Q4 2015. 182 funds tracked by Wall St. Rank hold PCRX as of Q4 2016.

  • MSI Financial Services held 116 shares of Pacira BioSciences worth $4K as of Q4 2016.
  • MSI Financial Services left its Pacira BioSciences share count unchanged in Q4 2016.
  • Pacira BioSciences made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3248 holding.
  • MSI Financial Services first reported a position in Pacira BioSciences in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's Pacira BioSciences position peaked at $9K in Q4 2015.
  • 182 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.